全文获取类型
收费全文 | 1823篇 |
免费 | 202篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 165篇 |
妇产科学 | 31篇 |
基础医学 | 267篇 |
口腔科学 | 91篇 |
临床医学 | 224篇 |
内科学 | 347篇 |
皮肤病学 | 49篇 |
神经病学 | 37篇 |
特种医学 | 181篇 |
外科学 | 308篇 |
综合类 | 42篇 |
预防医学 | 106篇 |
眼科学 | 42篇 |
药学 | 55篇 |
中国医学 | 2篇 |
肿瘤学 | 99篇 |
出版年
2023年 | 14篇 |
2022年 | 10篇 |
2021年 | 18篇 |
2020年 | 14篇 |
2019年 | 9篇 |
2018年 | 50篇 |
2017年 | 46篇 |
2016年 | 43篇 |
2015年 | 64篇 |
2014年 | 79篇 |
2013年 | 107篇 |
2012年 | 53篇 |
2011年 | 42篇 |
2010年 | 84篇 |
2009年 | 95篇 |
2008年 | 36篇 |
2007年 | 62篇 |
2006年 | 59篇 |
2005年 | 45篇 |
2004年 | 48篇 |
2003年 | 40篇 |
2002年 | 55篇 |
2001年 | 30篇 |
2000年 | 39篇 |
1999年 | 47篇 |
1998年 | 114篇 |
1997年 | 91篇 |
1996年 | 108篇 |
1995年 | 71篇 |
1994年 | 80篇 |
1993年 | 40篇 |
1992年 | 23篇 |
1991年 | 31篇 |
1990年 | 18篇 |
1989年 | 35篇 |
1988年 | 35篇 |
1987年 | 30篇 |
1986年 | 27篇 |
1985年 | 28篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 22篇 |
1981年 | 15篇 |
1980年 | 16篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1975年 | 10篇 |
1974年 | 2篇 |
排序方式: 共有2053条查询结果,搜索用时 0 毫秒
101.
目的利用4种不同支架材料构建复合式口腔黏膜,并比较其组织结构特点。方法体外培养人口腔黏膜的成纤维细胞和角质形成细胞,在4种支架材料中加入成纤维细胞,培养7d后,在支架表面加入角质形成细胞,培养4d后,移至气-液界面继续培养7d。苏木精-伊红染色镜下观察构建的复合式口腔黏膜的组织形态学特点。结果 4种支架均可构建形成复层上皮。其中,上皮层与脱细胞真皮基质材料(de-epidermised dermis,DED)结合紧密,形成的人工黏膜有明显的上皮钉突。不同于以往报道,上皮层与Alloderm结合并不十分紧密。以胶原凝胶为基质形成的人工口腔黏膜最厚,有明显分层。以胶原海绵-胶原凝胶为基质形成的复层上皮在部分区域长入至胶原海绵的空隙中。结论以DED和胶原凝胶为支架构建的口腔黏膜更接近于天然结构,而后者脆性较大,限制了其临床应用的可能。 相似文献
102.
Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease 总被引:5,自引:0,他引:5
Autologous stem cell transplantation (ASCT) has been proposed as a possible treatment for severe autoimmune diseases such
as rheumatoid arthritis (RA), multiple sclerosis (MS), systemic sclerosis, and systemic lupus erythematosus (SLE). To date,
more than 250 patients with various autoimmune disorders have undergone an ASCT since 1996. Among them, there is a very limited
number of children. This review summarizes the experience with ASCT for pediatric rheumatic diseases. Most reported cases
concern juvenile idiopathic arthritis (JIA). Experience with ASCT for childhood SLE, Scleroderma, or Dermatomyositis is very
limited. To date, 12 children with severe systemic or polyarticular JIA, all with progressive disease activity despite the
use of corticosteroids, MTX, CsA, or Cyclophosphamide were treated in our center with ASCT. Rheumatologic follow-up at 3-month
intervals up to 36 months showed a marked decrease in arthritis severity as expressed by the core-set criteria for juvenile
chronic arthritis (JCA) activity. However, these children remain at risk for severe viral infections due to the prolonged
lymfopenia. ASCT in this severely ill patient group induces a very significant and drug-free remission of the disease, but
carries a significantly risk of developing fatal MAS. 相似文献
103.
Monocytoid B-cell lymphoma: its evolution and relationship to other low- grade B-cell neoplasms 总被引:3,自引:0,他引:3
Monocytoid B-cell lymphoma (MBCL) is a newly recognized B-cell neoplasm of uncertain histogenesis. The cytologic features of the neoplastic monocytoid B lymphocytes are virtually identical to those of hairy cell leukemia (HCL). As with HCL, progression of MBCL to a higher histologic grade is very unusual. However, whereas circulating leukemic cells are a characteristic feature of HCL, peripheral blood involvement has not been reported in MBCL. We recently studied a patient with MBCL of the spleen and axillary lymph nodes who developed peripheral blood involvement by MBCL cells. Unlike the cells of HCL, the circulating MBCL cells exhibited strong acid phosphatase activity that was tartrate sensitive. The leukemic cells had the antigenic phenotype IgM lambda, CD20+, CD11c+, CD5-, CD25(TAC)-, and PCA-1-. Immunogenetic studies of both lymph node and peripheral blood cells revealed identical immunoglobulin heavy-chain gene rearrangements. When compared with a series of HCL, the immunophenotype was similar except for the absence of PCA-1 and TAC. Progression of the MBCL to a large cell lymphoma, also expressing IgM lambda, was documented in an abdominal lymph node of this patient. Therefore, although rare, peripheral blood involvement by lymphoma cells may occur during the course of MBCL and should be distinguished from HCL with cytochemical and immunophenotypic studies. In addition, comparison of the clinical, pathologic, and immunologic features of MBCL with those of other low-grade B-cell neoplasms suggests that a close lineage relationship exists between MBCL and HCL. 相似文献
104.
Prospective evaluation of posttransfusion hepatitis 总被引:1,自引:0,他引:1
G Sirchia ; AM Giovanetti ; A Parravicini ; A Bellobuono ; F Mozzi ; MN Pizzi ; D Almini 《Transfusion》1991,31(4):299-302
The incidence of posttransfusion hepatitis (PTH) was determined prospectively at our institution. An active surveillance program of transfused surgical patients was set up; alanine aminotransferase (ALT) levels were determined before transfusion and at monthly intervals for 6 months after transfusion. Patients with confirmed ALT values greater than 2.5 times the upper reference values were referred to the out-patient clinics for diagnosis. Of 4051 surgical patients who underwent transfusion between January 1986 and December 1989, 2459 (60.7%) were enrolled in the surveillance program, and 1018 (25.1%) completed the follow-up; 238 patients received autologous blood only and were used as controls. No PTH was observed in the control patients, and the incidence of the disease in patients receiving homologous blood was 10.97 percent in 1986, 6.58 percent in 1987, 5.55 percent in 1988, and 4.29 percent in 1989; the decreasing trend is significant (p = 0.018). 相似文献
105.
F Bambi ; LB Faulkner ; C Azzari ; AM Gelli ; A Tamburini ; V Tintori ; AA Lippi ; F Tucci ; G Bernini ; F Genovese 《Transfusion》1998,38(1):70-74
BACKGROUND: An increasing number of apheresis machines are becoming available for peripheral blood progenitor cell (PBPC) collection in children. STUDY DESIGN AND METHODS: At the Children's Hospital of Florence (Italy), three apheresis machines were evaluated: MCS 3P (Haemonetics) (10 procedures in 4 patients, aged 10–12 years, weight 23.5-64 kg), Spectra, (COBE) (8 procedures in 3 patients, aged 4–17 years, weight 19–59 kg), and AS104 (Fresenius) (24 procedures in 9 patients, aged 2–16 years, weight 13.6-60 kg). For PBPC quantitative analysis, CD34 cytofluorimetry was employed. Relevant variables analyzed included efficiency of CD34+ cell extraction and enrichment, mononuclear cell purity and red cell contamination of the apheresis components, and platelet count decreases after leukapheresis. RESULTS: No significant differences in CD34+ cell-extraction abilities were found. However, the AS104 provided consistently purer leukapheresis components in terms of mononuclear cell and CD34+ cell enrichment (441 +/− 59%, vs. 240 +/− 35% and 290 +/− 42% for MCS 3P and Spectra, respectively). Postapheresis platelet counts dropped the least with the AS104. The smallest patient who underwent apheresis with MCS 3P (the only machine working on discontinuous flow and hence with greater volume shifts) weighed 23.5 kg and tolerated the procedure well, with no signs of hemodynamic instability. No significant complications were observed. CONCLUSION: All machines seem to have comparable PBPC extraction efficiency, but the AS104 seems to give the component with the greatest PBPC enrichment. This feature might be relevant for further ex vivo cell processing (CD34+ cell selection, expansion, and so on). 相似文献
106.
Hematopoietic growth factors (HGFs) interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) individually have been shown to increase the percentage of acute myeloid leukemia (AML) blasts in S phase and enhance the cytotoxic effects of Ara-C against these blasts in culture. We compared in vitro the effects of a combined treatment with GM-CSF (10 ng/mL) plus IL-3 (10 ng/mL) on the metabolism and cytotoxicity of Ara-C in normal bone marrow mononuclear cells (NBMMC) and AML blasts. NBMMC from six healthy volunteers and AML blasts from 10 patients were incubated for 20 hours with or without IL- 3 plus GM-CSF, followed by a concurrent treatment with Ara-C for 4 additional hours. Exposure to the HGFs and Ara-C produced significantly higher intracellular Ara-CTP levels as well as higher Ara-CTP/dCTP pool ratios in AML blasts as compared with NBMMC. Treatment with HGFs resulted in [3H] Ara-C DNA incorporation that was significantly higher in AML blasts versus NBMMC. This selective improvement of Ara-C metabolism in AML blasts was associated with an enhanced Ara-C-mediated leukemia colony-forming unit (CFU) growth inhibition. In contrast, exposure to HGFs resulted in an improved colony growth of normal CFU granulocyte-monocyte and CFU-granulocyte, erythroid, monocyte, megakaryocyte. These in vitro studies indicate that a combined treatment with IL-3 plus GM-CSF may improve the selectivity of Ara-C against AML blasts. 相似文献
107.
Rank MR Hirschl TA 《The journals of gerontology. Series B, Psychological sciences and social sciences》1999,54(4):S184-S193
OBJECTIVES: This study estimates the age-specific and cumulative proportions of American adults who will experience poverty at some point during their elderly years. These life-span proportions represent a substantially different approach to understanding poverty than calculating either yearly cross-sectional rates or poverty spell durations. METHODS: Our estimations are derived through a series of life tables built upon 25 waves of the Panel Study of Income Dynamics (PSID). RESULTS: The analyses indicate that 40% of America's elderly population will experience a year below the poverty line at some point between the ages of 60 and 90, and 48% of elders will experience poverty at the 125% level. The data further reveal that this life-span risk of poverty has remained relatively stable throughout the period of data collection (1968-1992). Finally, the likelihood of elderly Americans ever encountering a year below the poverty line increases dramatically for those who are Black, not married, and/or who have less than 12 years of education. DISCUSSION: Our results suggest that in spite of relatively low cross-sectional rates of elderly poverty in America, the likelihood of impoverishment at some point during the later years of life remains a very real possibility. 相似文献
108.
Hirschl M Hirschl K Lenz M Katzenschlager R Hutter HP Kundi M 《Arthritis and rheumatism》2006,54(6):1974-1981
OBJECTIVE: To assess the early signs, risk factors, and rate of transition from primary Raynaud's phenomenon (primary RP) to secondary RP. METHODS: A clinical sample of 307 consecutive patients with RP was included in a prospective followup study. After an initial screening, 244 patients were classified as having primary RP, of whom 236 were followed up for a mean +/- SD of 11.2 +/- 3.9 years. Patients classified according to the screening as having suspected secondary RP underwent an extended screening program annually until transition to secondary RP occurred. RESULTS: The initial prevalence of secondary RP was 11%. The annual incidence of transition to suspected secondary RP was 2%, and the annual incidence of transition to secondary RP was 1%. Overall, 46 patients were classified as having suspected secondary RP, and 23 of these later were classified as having secondary RP. Older age at onset of RP (hazard ratio 2.59, 95% confidence interval [95% CI] 1.40-4.80), shorter duration of RP at enrollment (hazard ratio 0.87, 95% CI 0.81-0.94), and abnormal findings on thoracic outlet test (hazard ratio 2.69, 95% CI 1.12-6.48) were associated with an increased risk for transition to secondary RP. Compared with patients with suspected secondary RP, those diagnosed as having secondary RP had a higher number and earlier occurrence of pathologic findings. Furthermore, antinuclear antibodies at a titer of > or = 1:320 and positive findings in specific serologic subsets were associated with a significantly increased risk for developing a connective tissue disease. CONCLUSION: Patients diagnosed initially as having primary RP may actually comprise 1 of 3 groups: those with idiopathic RP, those with a rather benign disease course, and those with a more severe course of the disease. 相似文献
109.
Debelenko LV; Brambilla E; Agarwal SK; Swalwell JI; Kester MB; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Chandrasekharappa SC; Crabtree JS; Kim YS; Heppner C; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Collins FS; Travis WD; Emmert-Buck MR 《Human molecular genetics》1997,6(13):2285-2290
Lung carcinoids occur sporadically and rarely in association with multiple
endocrine neoplasia type 1 (MEN1). There are no well defined genetic
abnormalities known to occur in these tumors. We studied 11 sporadic lung
carcinoids for loss of heterozygosity (LOH) at the locus of the MEN1 gene
on chromosome 11q13, and for mutations of the MEN1 gene using dideoxy
fingerprinting. Additionally, a lung carcinoid from a MEN1 patient was
studied. In four of 11 (36%) sporadic tumors, both copies of the MEN1 gene
were inactivated. All four tumors showed the presence of a MEN1 gene
mutation and loss of the other allele. Observed mutations included a 1 bp
insertion, a 1 bp deletion, a 13 bp deletion and a single nucleotide
substitution affecting a donor splice site. Each mutation predicts
truncation or potentially complete loss of menin. The remaining seven
tumors showed neither the presence of a MEN1 gene mutation nor 11q13 LOH.
The tumor from the MEN1 patient showed LOH at chromosome 11q13 and a
complex germline MEN1 gene mutation. The data implicate the MEN1 gene in
the pathogenesis of sporadic lung carcinoids, representing the first
defined genetic alteration in these tumors.
相似文献
110.